Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Transcriptomic profile of the hippocampus of rat strains with contrasting nervous system excitability

  • Marina Pavlova,

    Roles Conceptualization, Formal analysis, Visualization, Writing – review & editing

    Affiliation Pavlov Institute of Physiology of the Russian Academy of Sciences, Saint-Petersburg, Russia

  • Irina Shalaginova ,

    Roles Conceptualization, Investigation, Writing – original draft

    shalaginova_i@mail.ru

    Affiliation Pavlov Institute of Physiology of the Russian Academy of Sciences, Saint-Petersburg, Russia

  • Natalia Dyuzhikova

    Roles Conceptualization, Funding acquisition, Writing – review & editing

    Affiliation Pavlov Institute of Physiology of the Russian Academy of Sciences, Saint-Petersburg, Russia

Abstract

Individual variability of reactions to environmental influences which determines the range of the “reaction norm” and the possibilities of adaptation is strongly shaped by inherited properties of the nervous system, including genetically determined differences in excitability. Rat strains selectively bred for contrasting thresholds of neural system excitability provide a model for studying how such inherited differences are reflected at the molecular level. Here, we performed bulk RNA sequencing of the hippocampus in high-excitability (LT) and low-excitability (HT) rats to characterize baseline interstrain transcriptomic divergence. Differential expression analysis revealed strain-specific transcriptional profiles involving not only synapse- and plasticity-related genes, but also non-neuronal components associated with glial/immune functions, intracellular trafficking and protein processing, kinase signaling, extracellular matrix remodeling, and neurovascular regulation. Functional annotation highlighted differences in synaptic organization, neuronal projection development, cellular maintenance pathways, and tissue-level regulatory processes. The analysis motivates testable hypotheses involving synaptic/neurite organization, cellular maintenance pathways (MAPK/PI3K-linked trafficking and redox regulation), and glial/neurovascular components, to be evaluated in follow-up studies using structural and functional tissue-level measurements. This work also provides a reference for cross-model comparisons of polygenic excitability-related traits, as a reference transcriptomic profile from a long-term selective-breeding paradigm.

Introduction

Individual variability of reactions to environmental influences, including physical, chemical, and psychosocial stimuli, is a fundamental property of organisms with a complex nervous system. One of the main factors determining such variability is the excitability of the nervous system, a genetically encoded trait that is associated with the threshold and dynamics of neural responses [1]. Thus, a deeper understanding of the molecular and genetic mechanisms underlying inherited differences in excitability is crucial to identify biological risk factors and pathways that determine adaptation reserves and may contribute to vulnerability or resilience to various pathologies, including, but not limited to, stress-related disorders.

One of the effective strategies for investigating complex traits is the use of selectively breeding of model organisms, allowing for controlled genetic divergence along specific behavioral or physiological axes. Notable examples include rats bred for high vs. low anxiety-like behavior (HAB vs. LAB), which differ in coping strategies and HPA axis reactivity [2], and high- vs. low-responder strains (bHR/bLR), which show stable differences in emotional reactivity and PTSD-like behavior [3]. However, these models are typically based on behavioral selection, which may be confounded by uncontrolled factors and the complexity of interpretation of behavioural tests that were used for selection.

In contrast, our model is based on a direct and quantifiable physiological trait – tibial nerve excitability threshold – which reflects fundamental properties of neuronal responsiveness [4]. Long-term selection for this trait has produced two strains: low-threshold (LT, high-excitability) and high-threshold (HT, low-excitability) rats. These strains exhibit stable differences in CNS excitability and behavioral profiles [5,6], making them a valuable system for dissecting the molecular basis of inherited excitability.

Given the hippocampus’s key role in regulating neural excitability, emotional processing, and stress response, and its established involvement in excitability-related pathologies [7], we selected this structure to investigate transcriptomic differences between the strains.

The specific tasks were: 1) to determine which genes show differential expression (DEGs) in the hippocampus between LT and HT strains; 2) to characterize the functional structure of the interstrain transcriptomic divergence by Gene Ontology (GO) annotation of DEGs (biological processes, cellular components, and molecular functions); 3) to explore the organization of DEGs into interaction modules by constructing protein–protein interaction (PPI) networks and identifying clustered modules for key enriched functional categories.

This design is not intended to show causal links between gene expression and phenotype, rather, it aims to map interstrain transcriptomic differences in the hippocampus of intact rats formed as a result of selection for high and low thresholds of nervous system excitability. These transcriptional profiles provide a baseline reference for subsequent studies of stress- or aging-related effects in the context of heritable differences in excitability, because they allow to predict the nature of the reaction to stress and other extreme factors depending on the genetic background associated with high and low excitability, as well as to distinguish expression changes that occur along the pre-existing interstrain axes from novel, exposure-induced shifts. In addition, this approach helps to identify a limited set of consistent modules as candidates for subsequent testing of their functional relevance.

Methods

Animals

Male rats (5 months old, n = 5 per group) from two selectively bred strains (F72)— HT (high-threshold, low-excitability) and LT (low-threshold, high-excitability) were used in this study. The strains were developed at the I.P. Pavlov Institute of Physiology, Russian Academy of Sciences, by selective breeding from an outbred Wistar population, with the aim of studying how neural excitability influences behavioral and physiological phenotypes. These strains are included in the official biocollection at the Pavlov Institute of Physiology, RAS (NoGZ 0134-2018-0003), with patents for selective breeding (No 10769 and 10768).

The selection criterion was the threshold of neuromuscular excitability, determined by electrical stimulation of the tibial nerve (n. tibialis) with 2-ms electrical impulses. The first two generations were obtained by sibling mating, and subsequent breeding was performed within each strain. By the 10th generation, the differences between the strains had stabilized, exceeding the within-strain variability by more than fourfold. The animals used in the present study belonged to the 76th generation of this long-term selective breeding program. Nervous system excitability was routinely assessed both during the breeding program, to select animals for further within-line mating, and during the formation of experimental cohorts. Supplementary material (S_1) shows the individual excitability threshold values of the HT and LT rats used in the present study, confirming the phenotypic separation of the two strains in the analyzed cohort.

Animals from both strains were randomly selected for the experiment and kept in a shared vivarium room under controlled conditions (23 ± 2 °C, 12 h light/dark cycle) with free access to standard chow and water. Rats were group-housed (three animals per cage) until 5 months of age, after which they were decapitated in an intact state. Animals were inspected daily by trained animal-care staff, and all procedures were designed to minimize distress. The study involved terminal tissue collection from intact rats at a predefined time point and did not include survival surgery or prolonged invasive manipulations before euthanasia. Decapitation was performed rapidly by experienced personnel to minimize handling time and distress. Anesthesia was not used because agents such as inhalational anaesthetics such as isoflurane can rapidly alter cytokine and other immune-related genes expression [8] which would compromise the primary transcriptomic endpoint of the study and reduce the scientific validity of the terminal sampling procedure. The hippocampus was dissected according to the coordinates of the stereotactic atlas of the rat brain [9]. No humane endpoints were required, as animals were euthanized at the planned time point without prior invasive procedures. All procedures complied with the European Community Council Directive 2010/63/EU and were approved by the Institutional Animal Care and Use Committee of the Pavlov Institute of Physiology, RAS (Protocol No. 09/16, 16.09.2021) and follow the ARRIVE 2.0 guidelines for in vivo experiments. All animals were included in the analysis; no pre-established exclusion criteria were applied.

Tissue collection, RNA extraction and sequencing

Hippocampal tissue was collected under RNase-free conditions. The brain was rapidly removed and placed on an ice-cooled dissection surface. The whole hippocampus was dissected on ice with care to avoid inclusion of ventricular/ependymal tissue and visible large blood vessels. Tissue was transferred into RNAlater (Thermo Fisher Scientific, Ambion). Total RNA was extracted from hippocampal tissue using Trizol reagent followed by the PureLink RNA Micro Kit (Invitrogen, Carlsbad, CA, USA), according to the manufacturer’s protocol after tissue homogenization. Sequencing was performed at the Genoanalitika Lab, Moscow, Russia. The quality and quantity of the isolated total RNA were assessed using a BioAnalyzer with the RNA 6000 Nano Kit (Agilent). The poly(A) RNA fraction was then purified using oligo(dT) magnetic beads (Dynabeads® mRNA Purification Kit, Ambion) according to the manufacturer’s instructions.

cDNA libraries for high-throughput sequencing were prepared from the poly(A) RNA using the NEBNext® Ultra™ II RNA Library Prep Kit (New England Biolabs). Library concentrations were measured with the Qubit dsDNA HS Assay Kit (Thermo Fisher Scientific) on a Qubit 2.0 fluorometer, and fragment size distribution was evaluated using the Agilent High Sensitivity DNA Kit (Agilent, CA, USA). Single-end sequencing was performed on an Illumina HiSeq1500 platform (Illumina, San Diego, CA, USA), generating at least 20 million 50-bp reads per sample. RNA extraction, library preparation, and sequencing were performed simultaneously for all hippocampal samples

Read mapping and gene-level quantification were carried out with STAR 2.7.9a [10]. Default settings were applied except for outFilterMismatchNmax = 3, which restricted the number of mismatches per read to three. Reads were aligned to the Rnor_6.0 reference genome using Ensembl v.99 annotation. Raw gene-level counts were generated within STAR [10] with the quantMode GeneCounts option.

Differential expression analysis was performed in R with DESeq2 (v.1.28.1) [11]. Size-factor normalization was carried out with the estimateSizeFactors() function based on the median-of-ratios approach, and dispersion parameters were estimated using estimateDispersions(). Differentially expressed genes were identified with the DESeq() function. Group comparisons were evaluated with the Wald test, and p values were adjusted for multiple testing by the Benjamini-Hochberg false discovery rate (FDR) procedure.

RNA sequencing analyses

DEGs were identified using an FDR-adjusted significance threshold of padj < 0.05. This criterion was used as the primary statistical threshold for differential expression and controls the expected proportion of false discoveries among the genes declared significant. No mandatory log2 fold-change cutoff was applied for DEG definition, because the comparison involved intact animals under baseline physiological conditions, where moderate but statistically consistent expression differences may be biologically meaningful. The additional threshold of |log2FoldChange| ≥ 0.379, corresponding approximately to a 1.3-fold change, was used only to reduce the number of genes displayed in the circular heatmap and to improve visualization of genes with more pronounced inter-line differences.

Gene Ontology (GO) enrichment analysis was performed using DAVID [12] (Database for Annotation, Visualization and Integrated Discovery; DAVID Knowledgebase v2025_1, released April 17, 2025) to identify functional categories overrepresented among the DEGs. Up- and down-regulated genes were analyzed together as a single DEG list, because the aim was to characterize the functional composition of genes differing between the lines rather than to infer direction-specific pathway activation. Gene identifiers were analyzed against the full set of expressed genes detected in our RNA-seq dataset, which was used as the background gene set. GO Biological Process (BP), Cellular Component (CC), and Molecular Function (MF) categories were analyzed. Enrichment significance was assessed using the DAVID functional annotation enrichment procedure, with multiple-testing correction based on the false discovery rate (FDR). Terms were considered significant at p < 0.05 and FDR q < 0.1.

Statistically significant GO terms were manually reduced to a representative non-redundant subset by grouping terms with similar biological meaning and/or overlapping DEG composition and retaining one representative term per group, prioritizing higher specificity, lower FDR values, and relevance to the biological focus of the study.

Data visualization and plotting were performed using the SRplot online platform (https://www.bioinformatics.com.cn; accessed May 1, 2025; updated April 2025) [13]. The following types of plots were generated:

  • Volcano plot – selection criterion: padj < 0.05 (FDR);
  • Principal Component Analysis (PCA) – selection criterion: padj < 0.05 (FDR); To avoid circularity associated with PCA based on DEGs, PCA was additionally performed using the transcriptome-wide background expression matrix without DEG-based gene selection. For this analysis, all expressed genes were retained after removal of genes with zero expression or zero variance across samples.
  • Circular cluster heatmap – selection criteria: padj < 0.05 (FDR) and |log2FC| > 0.379; this threshold corresponds to a change in the level of gene expression by more than 1.3 times (or less than 1/1.3 ≈ 0.77 times). The use of an additional filter made it possible to select DEGs with the most pronounced differences in expression levels in order to reduce their total number to the optimal one for clearer visualization of clusters on a Circular cluster heatmap; clustering based on Euclidean distance, expression data normalized by z-score;
  • GO/ Pathway Enrichment plots – selection criteria for DEGs is padj < 0.05 (FDR); for GO-Enrichment pathways is p value < 0.05; padj < 0.1.
  • The STRING database (version 12.0) was used to construct and analyze the protein–protein interaction (PPI) network. The analysis included both direct (physical) and indirect (functional) interactions derived from curated databases, experimental evidence, and computational predictions. The confidence score threshold was initially set at 0.4 and then increased to 0.7 to retain only high-confidence associations and obtain clearer clustering. Clusters within the PPI network were identified using the Markov Cluster Algorithm (MCL) with the inflation parameter set to 1.5 [14]. For the construction of PPI networks, we focused on differentially expressed genes (DEGs) associated with specific BP term.

Raw and processed RNA-seq data were deposited in the NCBI Gene Expression Omnibus (GEO) under accession number GSE327807.

Results

Differential gene expression in the hippocampus of rat strains with contrast levels of neural excitability

The direction and fold changes were determined for the LT strain relative to the HT strain. A total of 654 differentially expressed genes (DEGs) were identified, of which 270 showed higher expression in the LT and 384 in the HT (padj < 0.05) (Fig 1).

thumbnail
Fig 1. Differentially expressed genes in the hippocampus of high-excitability (LT) and low-excitability (HT) strains.

Cut off: padj ≤0,05 (FDR).

https://doi.org/10.1371/journal.pone.0350674.g001

Inspection of the top DEGs suggested several broad functional groupings: a vascular/immune-associated set; a trafficking/protein-homeostasis-related; and a neuronal signaling/structural. Table 1 presents the top-DEGs highlighted on the Fig 1.

thumbnail
Table 1. ТOP-DEGs: Functional roles and general information*.

https://doi.org/10.1371/journal.pone.0350674.t001

Principal component analysis (PCA) based on the 654 DEGs demonstrated complete separation between LT and HT samples, with the first two principal components explaining 81.7% of the total variance (Fig 2A). The additional PCA was performed using the transcriptome-wide background expression matrix without DEG-based gene selection (Fig 2B). In this analysis, separation between LT and HT samples was also preserved, although the proportion of variance explained by the first two principal components was lower (32.7%), consistent with the use of an unbiased transcriptome-wide gene set rather than genes selected for differential expression.

thumbnail
Fig 2. Principal component analysis (PCA) of hippocampal transcriptomic profiles in HT and LT rat strains.

(A) PCA based on 654 differentially expressed genes (DEGs; padj ≤ 0.05). (B) PCA based on all expressed genes after removal of genes with zero expression or zero variance across samples. LT – high-excitability; HT – low-excitability.

https://doi.org/10.1371/journal.pone.0350674.g002

Fig 3 presents a circular heatmap of the expression profiles of 167 DEGs. The diagram shows two main gene clusters: (1) genes with higher expression in the LT strain (70 DEGs) and (2) genes with lower expression in the LT strain (97 DEGs).

thumbnail
Fig 3. Сirkular claster heatmap for 167 DEGs expression in the hippocampus of HT and LT rat strains.

Cut off: padj ≤0,05 (FDR), |log2fold change| ≥ 0,379). LT – high-excitability; HT – low-excitability. LT1-LT5, HT1-HT5 – samples; red color – up regulation, blue color – down regulation (LT vs HT).

https://doi.org/10.1371/journal.pone.0350674.g003

Together, the DEGs, PCA, and heatmap results supported the presence of a structured interstrain expression signature in the hippocampus and motivated subsequent functional annotation analysis.

Gene ontology (GO) enrichment analysis

To explore the biological significance of the 654 differentially expressed genes, GO enrichment analysis was performed (Fig 4).

thumbnail
Fig 4. Gene Ontology-based functional annotation of the differentially expressed genes across biological process (A), cellular component (B), and molecular function (C) categories.

The x-axis indicates the GeneRatio, representing the proportion of DEGs annotated to a given GO term. The color gradient of the dots corresponds to the adjusted p-value (FDR), dot size corresponds to the number of genes annotated to each term.

https://doi.org/10.1371/journal.pone.0350674.g004

Among the identified GO biological process (BP) pathways (Fig 4A), the most enriched and biologically relevant include “regulation of the MAPK cascade”, “neuron projection morphogenesis”, “regulation of neuron projection development”, “supramolecular fiber organization” and “gliogenesis”. Also, the pathways directly related to the regulation of behavior under normal and pathological conditions, such as “synapse organization”, “cognition”, “learning or memory”, “regulation of synaptic plasticity”, “generation of precursor metabolites and energy”, and “extracellular matrix organization”.

The most enriched GO pathways for cellular components (CC) (Fig 4B) were “neuron-to-neuron synapse”, “side of membrane”, “extracellular matrix”, “cell leading edge”, “distal axon”, “Golgi apparatus subcompartment” and “secretory granule”.

For molecular functions (MF) (Fig 4C), the most significant categories included “signaling receptor activity”, “oxidoreductase activity” and “calcium ion binding”.

Overall, the GO analysis indicated several major functional trends in the strain hippocampal transcription profiles. Beyond broad synaptic/plasticity-related categories, the enriched terms also pointed to neuronal process development, glial-associated functions, extracellular matrix organization, kinase-related signaling, intracellular trafficking, and metabolic/redox-related processes. Because GO analysis indicated several coherent functional themes, we next asked whether selected categories were also supported by network-level interactions among their gene products.

Protein-protein interactions

STRING analysis of the complete DEG set (654 genes, FDR < 0.05) demonstrated significant protein–protein interaction enrichment (639 nodes, 547 edges; 381 expected edges; average node degree: 1.71; PPI enrichment p = 7.77 × 10−16), indicating that the transcriptomic differences between HT and LT strains are not randomly distributed across independent genes but are partially organized into interconnected molecular systems (S2 Fig).

To further examine the functional organization of selected DEG subsets associated with biologically relevant GO categories, we next constructed focused PPI networks for genes involved in regulation of synaptic plasticity and regulation of the MAPK cascade (Figs 5 and 6).

thumbnail
Fig 5. Protein–protein interaction network for genes involved in regulation of synaptic plasticity.

Cluster 1 (red, 18 genes) – Regulation of synaptic plasticity. Cluster 2 (green, 2 genes: Grin2c, Grik1) – Ionotropic glutamate receptor activity. Cluster 3 (blue, Penk and Vgf) – not annotated in STRING.

https://doi.org/10.1371/journal.pone.0350674.g005

thumbnail
Fig 6. Protein–protein interaction network for genes involved in regulation of MAPK cascade.

Cluster 1 (red, 12 genes) – regulation of phospholipase activity, Cluster 2 (yellow, 7 genes) – positive regulation of myeloid leukocyte differentiation, Cluster 3 (green, 5 genes) receptors involved in neurotrophic and GPCR signaling, Cluster 4 (cyan, 3 genes) – cytoskeletal components involved in microvillus assembly and myosin II binding, Cluster 5 (purple, 3 genes) – transcriptional regulators of early cell fate decisions. Genes not integrated into any cluster due to insufficient interaction evidence are shown as unconnected white nodes.

https://doi.org/10.1371/journal.pone.0350674.g006

To explore functional relationships among the genes contributing to the enriched GO term “regulation of synaptic plasticity” (GO:0048167), we constructed a PPI network using the STRING database. The network included 22 nodes connected by experimentally validated or predicted interactions. MCL clustering revealed three functional modules (Fig 5). The network of 29 nodes connected by 51 edges, whereas only 6 edges would be expected for a random set of this size. The network showed highly significant PPI enrichment (p < 1.0 × 10−16), with an average node degree of 3.52 and a local clustering coefficient of 0.497, supporting the presence of a non-random and moderately clustered interaction structure. Cluster 1 (red, 18 genes) represents the core synaptic plasticity module, encompassing key regulators of neurotransmission and cytoskeletal organization such as Snap25, Camk2a, Ntrk2, Mapt, and Gfap. Cluster 2 (green, 2 genes: Grin2c, Grik1) corresponds to ionotropic glutamate receptor activity, directly linking to postsynaptic excitatory signaling. Cluster 3 (blue, Penk and Vgf) includes neuropeptide-encoding genes associated with neurotrophic signaling and plasticity modulation.

The dense interconnections within Cluster 1 highlight a coordinated regulatory network that integrates synaptic vesicle trafficking, receptor signaling, and structural remodeling processes.

PPI analysis of the functional coherence of differentially expressed genes associated with the GO:0043408 ~ regulation of MAPK cascade pathway using the STRING database revealed five distinct clusters (Fig 6). The STRING network contained 57 nodes and 136 edges, whereas only 33 edges were expected by chance. The network showed highly significant PPI enrichment (p < 1.0 × 10−16), with an average node degree of 4.77 and a local clustering coefficient of 0.476, indicating a non-random and moderately clustered interaction structure.

Cluster 1 corresponds to regulation of phospholipase activity and includes key upstream modulators such as Agt, Ednra, Pdgfrb, Flt1, and Agtr1. Cluster 2 reflects genes involved in the positive regulation of myeloid leukocyte differentiation. Cluster 3 comprises receptors involved in neurotrophin and GPCR signaling (Ntrk2, Ntsr2, Gpr37l1, Rit2). Cluster 4 represents cytoskeletal components involved in microvillus assembly and myosin II binding (Ezr, Sln). Cluster 5 includes transcriptional regulators of early cell fate decisions (Sox2, Bmp4).

Overall, the PPI analysis helped to resolve selected DEG-associated categories into connected modules. The synaptic plasticity-related network contained modules centered on core synaptic genes, glutamate receptor-related components, and neuropeptide-associated genes, whereas the MAPK-related network was organized into smaller signaling, cytoskeletal, and transcription-related modules.

Discussion

Top DEGs (Table 1) can be used as concrete candidates for follow-up validation and for building minimal marker panels, which we then relate to the broader GO/PPI structure described below. Several top DEGs may be consistent with a non-neuronal vascular/immune-associated component of interstrain divergence: Serpinf2 (α2-antiplasmin; coagulation-related) [15], with broader serpin-family links to neurodegenerative conditions [16] and our prior observation of higher Serpinf2 mRNA in LT amygdala [17]; Stab2 (endothelial/myeloid transmembrane receptor), consistent with a heightened neuroimmune profile previously reported in LT amygdala [17]; Cd55 (complement regulation) [18,19]; and glia/innate-immunity candidates such as P2rx7 (predominantly glial purinergic receptor) [2022] with context-dependent signaling states [23], Slc2a5/GLUT5 (microglia-enriched fructose transporter) [2426], and Apobec1 (RNA-editing enzyme with reported roles in microglial inflammatory control and neurodegeneration) [27,28] and an epilepsy-related association [29]. Acer2 (sphingolipid metabolism) [30,31] may reflect differences in lipid/vascular or blood–brain barrier–related components rather than neuron-intrinsic expression changes. Because the present study is based on bulk hippocampal RNA-seq, these interpretations remain tentative and do not provide direct evidence of cell-type-specific expression changes. Further validation would require single-cell RNA sequencing or deconvolution analysis using suitable reference data.

Several top DEGs form a recurring pattern related to – ER-Golgi/endosomal trafficking and protein homeostasis. Slc35d3 links to Golgi/endosomal membranes and receptor trafficking pathways (D1 receptor trafficking shown in D1 neurons) [32] and has been connected to trafficking/autophagy-related processes [33]. Coro7 is a Golgi-localized trafficking/structure factor [34,35]. Tmem258b is associated with the oligosaccharyltransferase complex for N-linked glycosylation and ER stress pathways [27]. Together, these genes provide a short list of candidates for follow-up validation in trafficking/ER stress/protein quality control pathways across strains with contrast excitability.

A third group of top-DEGs captures neuronal circuit organization and activity-related signaling/regulation. Pcdha4 – (PCDHA cluster genes) are linked to neuronal connectivity and synapse specificity [36,37], with protocadherin mutations (e.g., PCDH19) associated with epilepsy and network hyperexcitability [38]. Vgf is an activity-regulated neuropeptide precursor induced by neurotrophic factors [39] and associated with hippocampal activity-dependent plasticity and learning [40], with broader biomarker/therapeutic discussions [41]. Grin2c (GluN2C NMDA receptor subunit) has distinct receptor properties and cell-type–restricted expression patterns [42], and NMDA receptors are broadly implicated in neuropsychiatric disease contexts [43]. Ift88 (primary cilia) is linked to neuronal signaling regulation and circuit formation [4446]. Prmt1l1 (PRMT1-like methyltransferase, poorly characterized) [47], together with PRMT-family links to excitability-related methylation (e.g., NALCN in a PRMT7 context) [48], points to a regulatory layer. Additional candidates in this broader “circuit support” space include Mtmr1 (myotubularin family; related family links to myelin regulation) [49,50].

Several enriched GO categories were related to synaptic organization and neuronal signaling, suggesting that one component of the baseline interstrain divergence in the hippocampus involves synaptic/plasticity-associated processes. This interpretation is supported by enrichment across BP, CC, and MF categories, although some of these terms are relatively broad (such as “cognition” and “learning and memory”) and should be viewed as higher-level functional descriptors rather than pathway-specific evidence on their own. In this context, the hippocampal profile may provide a useful reference for future studies asking whether stress exposure modifies pre-existing synaptic/plasticity-related differences between LT and HT rats or instead introduces new changes outside this axis.

Interestingly, we also found significantly higher expression of Grin2c in the HT strain, encoding the GluN2C subunit of the NMDA receptor, which may be relevant to differences in glutamatergic signaling and synaptic modulation. Other model demonstrate that resilient mice exposed to chronic stress show compensatory structural plasticity of postsynaptic compartments in the CA1 hippocampus and a shift of the AMPAR/NMDAR ratio toward NMDAR, whereas animals developing anhedonia display an increased AMPAR/NMDAR ratio [51]. Since AMPARs mediate fast excitatory currents and NMDARs, which require prior depolarization, allow Ca² ⁺ influx and trigger long-term plasticity processes such as LTP [52], such shifts in their balance raise the possibility of a molecular mechanism that may contribute to differences in the adaptability of hippocampal circuits associated with resilient or vulnerable behavioral phenotypes.

Another major enrichment theme involved neuronal process development and glial-related terms, including neuron projection morphogenesis, axon development, gliogenesis, and astrocyte differentiation, with corresponding CC enrichment in the cell projection membrane and cell cortex. The cell cortex is a thin, actin-rich layer underneath the plasma membrane that regulates membrane mechanics and shape; it is key to cell migration, division, and tissue morphogenesis, and has been implicated in cell differentiation during development [53]. The cell projection membrane refers to the specialized plasma membrane of neuronal extensions, such as axons and dendrites, where ion channels and receptors are concentrated [54]. Although our data identify this pathway only at the level of enrichment, its biological significance is well documented. This localization is functionally critical, for instance, the axon initial segment contains a high density of voltage-gated channels that makes it the dominant site for action potential initiation and regulation of synaptic inputs integration, intrinsic excitability, and transmitter release [55]. In hippocampal pyramidal neurons, ion channels such as Kv4.2 and HCN are differentially distributed along dendrites and shape local excitability and input integration [56]. Thus, enrichment of these СС terms and also “active ion transporter activity” in MF in our RNA seq dataset may reflect genetic differences between LT and HT rats in the molecular organization of neuronal processes, formation of dendritic-axonal architecture pointing to basis to variation in excitability and information processing strategies at the circuit level. In practical terms, these enrichment signals suggest that the interstrain divergence may involve differences in neuronal process architecture and compartmentalized membrane organization; therefore, the most informative follow-up study is at the morphological and functional levels (neurite/axon initial segment organization and circuit excitability measures).

Differences in term “gliogenesis” may indicate that the strains have different patterns of glial activation upon stimulus. For example, one possible interpretation is that hippocampal astrocytes may differ numerically or functionally: recent data have shown that hippocampal astrocytes are actively involved in regulating anxiety, responding with calcium waves to disturbing environmental stimuli and influencing behavior [57]. More reactive astrocytes can better control the concentrations of neurotransmitters (glutamate, GABA) and maintain a balance of excitation/inhibition.

A next enrichment clusters stress/adaptive-response terms (e.g., “response to wounding”, MAPK and PI3K/AKT regulation) together with Golgi/endosomal compartments (trans-Golgi network, secretory granules, multivesicular bodies) and oxidoreductase activity. While the Golgi apparatus and multivesicular bodies are known to participate in receptor trafficking and thereby contribute to synaptic plasticity under physiological conditions, they also play a crucial role in neuronal defense by regulating protein turnover, receptor degradation, and adaptive membrane remodeling during cellular stress [58]. Notably, in models of systemic inflammation/hepatic encephalopathy, increased multivesicular bodies in astrocytes has been interpreted as a compensatory response supporting gliovascular homeostasis [59], suggesting that astroglial endosomal stress-handling pathways may differ between LT and HT strains at baseline.

Similarly, MAPK and PI3K/AKT signaling pathways are not only central to long-term synaptic plasticity but also constitute major survival and stress-response cascades in neurons [60]. Genetic alterations in the MAP-ERK pathway are associated with neurodevelopmental disorders, while its aberrant activation in glial cells contributes to neuroinflammatory mechanisms of major neurodegenerative diseases such as Alzheimer’s, Parkinson’s, Huntington’s disease [61].

Enrichment of the MF term “oxidoreductase activity” suggests the involvement of antioxidant and redox-regulatory processes that may support neuronal homeostasis under conditions of increased excitability or metabolic demand in the brain [62]. Together with enrichment of Golgi/endosomal and MAPK/PI3K-related categories, this points to a baseline cellular-maintenance component of the interstrain hippocampal divergence. An important next step is to determine whether this signal is linked to specific cellular compartments, such as astrocytes, endothelium, or microglia, and whether it is reflected at the structural or protein level in the hippocampus.

Another enrichment theme was related to extracellular matrix organization. In the hippocampus, ECM, including perineuronal nets, not only provides structural support but also modulates plasticity, memory-related processes, receptor mobility, and the balance between excitation and inhibition [63]. Its role in plasticity regulation and in stress- or depression-related remodeling has been well documented [64].

Enrichment of metabolism-related categories further suggests strain-specific differences in energetic support and neurotransmitter-associated metabolic processes. For example, mitochondrial calcium uptake can enhance electron transport chain activity and ATP production during high-frequency firing in hippocampal neurons [65], while amino acid transporters involved in the glutamate-glutamine cycle help maintain transmitter supply under sustained synaptic load [66].

Thus, changes in gene expression in the hippocampus of LT and HT rats affect processes at several levels, from synaptic transmission and process morphogenesis to regulation of the extracellular environment and metabolic support, which provides the basis for further study of their functional significance.

The significant PPI enrichment of the complete DEG set indicates that the hippocampal differences between HT and LT rats are organized beyond the level of individual differentially expressed genes. The higher-than-expected number of interactions suggests that the DEG set is concentrated within functionally connected molecular neighborhoods. This is consistent with the nature of inherited nervous system excitability as a polygenic trait and selection is unlikely to produce a transcriptional signature restricted to a single canonical pathway. Instead, the enriched interaction structure suggests that baseline hippocampal divergence is distributed across connected molecular neighborhoods involving synaptic organization, signaling, cellular-maintenance, and glial/neurovascular components. This supports the view that the interstrain difference represents a coordinated tissue-level transcriptomic state linked to the long-term selective-breeding history of the strains, and provides the context for the focused analyses of synaptic plasticity- and MAPK-related DEG subsets.

In the synaptic plasticity-related network, several proteins point to processes such as vesicle cycling, calcium signaling, and synapse structural organization. Among them, SNAP25 (node degree = 9, S3 Table) is especially notable because, as a core SNARE-complex protein, it is directly involved in synaptic vesicle fusion and neurotransmitter release. Altered SNAP25 expression has been linked to cognitive and emotional disorders [67], and SNAP-25 also contributes to postsynaptic receptor trafficking and dendritic spine organization, indicating that its variation may influence both pre- and postsynaptic components of plasticity [68]. Another important node of this cluster is NTRK2 (TrkB, node degree = 9) – a BDNF receptor associated with plasticity, synaptic stability, and adaptive response to stress [69].

MAPT (tau, node degree = 10) is now considered not only as a protein “associated with microtubules”. There is increasing evidence of its involvement in synaptic regulation, microtubule stabilization, dendritic spike support, and memory consolidation. Tau removal in mice leads to age-related disorders of short-term memory and defects in synaptic plasticity [70]. The role of synaptic tau, i.e., tau localized in synapses, in the coordination of synaptic responses and plasticity is also discussed [71].

GFAP (glial fibrillar acid protein, node degree = 12) is a marker and structural component of astrocytes involved in the morphological plasticity of astrocytic processes and the regulation of homeostasis. Astrocytes and GFAP are important not only for supporting neurons, but also for modulating plasticity (for example, through environmental regulation, glutamate clearance, Ca2 ⁺ signals) [72]. Mutant GFAP mice models show decreased synaptic plasticity and impaired astrocyte function [73]. The differences in Gfap expression between the strains are consistent with the astrocyte stress response that we found earlier: 7 days after stress, the LT strain showed a decrease in the number of GFAP+ cells in the prefrontal cortex, hippocampus, and amygdala, whereas in HT rats such a decrease was limited only by the hippocampus [6].

The presence of MAPT and GFAP in this cluster indicates that the plastic changes reflected in the transcriptome are not limited to neurotransmitter mechanisms in synaptic transmission, as well as stabilization of the cytoskeleton, changes in astrocytic support. Such nodes are particularly interesting as candidates for subsequent verification: how can interstrain differences in MAPT expression affect the structural stability of dendrites in response to stress, and variations in GFAP expression affect glial reactivity and its ability to “service” neural networks?

Among the genes contributing to the MAPK cascade-related network, angiotensinogen (AGT, node degree = 12, S6 Table) is notable because angiotensinogen is expressed in both astrocytes and neurons [74]. Interstrain differences in basal AGT mRNA levels have been reported previously in rat: in Wistar astrocytes expression was higher compared to the spontaneously hypertensive rats (SHR) strain [75]. AGT is a precursor molecule of Ang II, which in astrocytes causes activation of several intracellular signaling pathways involving mitogen activated protein (MAP) kinases, tyrosine kinases, protein kinase C (PKC), immediate early response genes [76]. FLT1 (VEGFR1, node degree = 5), a receptor for vascular growth factor, is involved in neurovascular plasticity: its expression in the hippocampus increases after ischemic damage, which may reflect an attempt to regenerate or restructure the vascular network [77]. Differences in the expression of AGT and FLT1 suggest that the interstrain divergence may extend beyond synaptic genes to include pathways related to vascular signaling and possibly glia–vascular interactions within hippocampal tissue.

PDGFRB (platelet growth factor β-form receptor, node degree = 10) is involved in MAPK activation through binding to the growth factor receptor binding protein 2 (GRB2) and triggering the Ras/MAPK cascade. Multiple transcription factors, such as Elk-1, c-Jun and c-Myc, are catalyzed by MAPK activation and control cell metabolism, growth, and proliferation [78]. In nervous tissue, PDGF/PDGFR signaling regulates neurogenesis, cell survival, and remodeling of neural networks [79].

Thus, the largest cluster identified by the PPI analysis of genes associated with GO:0043408 “regulation of the MAPK cascade” included many modulators of kinase signaling pathways potentially relevant to vascular, glial, and hormonal responses.

Conclusion

The identified hippocampal transcriptomic profile provides a molecular baseline for the interstrain differences that have emerged through selection and helps identify candidate pathways that may contribute to differential responses to stress and other extreme factors depending on the differences in genetic background associated with high and low excitability.

Transcriptomic analysis of the hippocampus in rat strains with genetically determined differences in nervous excitability revealed divergence in molecular profiles not only at the level of neuronal factors related to neurons excitability, synaptic organization and structural neuroplasticity, but also non-neuronal factors related to glial function, cellular stress responses, MAPK signaling, extracellular matrix remodeling, and vascular regulation. This baseline profile provides a reference framework for interpreting future studies in this model, helping to distinguish constitutive interstrain differences from changes induced by experimental manipulations. Although the present bulk RNA-seq approach does not provide direct cell-type resolution and therefore requires further validation by cell-type-resolved methods, it help identify the major functional domains in which interstrain hippocampal divergence is organized. The analysis motivates testable hypotheses involving synaptic/neurite organization, cellular maintenance pathways (MAPK/PI3K-linked trafficking and redox regulation), and glial/neurovascular components, to be evaluated in follow-up studies using structural and functional tissue-level measurements. This work also provides a reference for cross-model comparisons of polygenic excitability-related traits, as a reference transcriptomic profile from a long-term selective-breeding paradigm.

Supporting information

S1 Fig. Individual excitability thresholds in selectively bred HT and LT rats.

https://doi.org/10.1371/journal.pone.0350674.s001

(DOCX)

S2 Fig. STRING PPI network from the full set of DEGs identified between HT and LT hippocampus samples.

https://doi.org/10.1371/journal.pone.0350674.s002

(PNG)

S2 Table. Fig 5 string MCL cluster descriptions.

https://doi.org/10.1371/journal.pone.0350674.s004

(XLS)

S5 Table. Fig 6 string MCL cluster descriptions.

https://doi.org/10.1371/journal.pone.0350674.s007

(XLS)

S8 Table. String node degrees of PPI network from the full set of DEGs.

https://doi.org/10.1371/journal.pone.0350674.s010

(TSV)

Acknowledgments

We would like to thank Genoanalytica Lab, Moscow, Russia, where the samples were sequenced and the initial data processing was carried out. We would also like to express our sincere gratitude to Professor Natalia Kudryavtseva, Doctor of Biological Sciences (Pavlov Institute of Physiology of the Russian Academy of Sciences), Olga Redina, Doctor of Biological Sciences (Institute of Cytology and Genetics of the Siberian Branch of the Russian Academy of Sciences) and Artur Shvetcov, Doctor of Philosophy (Senior Bioinformatician in Westmead Institute for Medical Research, Sydney, Australia) for their assistance and support in working with transcriptome analysis data.

References

  1. 1. Dyuzhikova N, Lopatina N. Genetically determined excitability of the nervous system: impact on brain function and behavior. Usp Fiziol Nauk. 2024;55:88–104.
  2. 2. Gryksa K, Schmidtner AK, Masís-Calvo M, Rodríguez-Villagra OA, Havasi A, Wirobski G, et al. Selective breeding of rats for high (HAB) and low (LAB) anxiety-related behaviour: a unique model for comorbid depression and social dysfunctions. Neurosci Biobehav Rev. 2023;152:105292. pmid:37353047
  3. 3. Prater KE, Aurbach EL, Larcinese HK, Smith TN, Turner CA, Blandino P Jr, et al. Selectively bred rats provide a unique model of vulnerability to PTSD-like behavior and respond differentially to FGF2 augmentation early in life. Neuropsychopharmacology. 2017;42(8):1706–14. pmid:28205604
  4. 4. Vaido A, Shiryaeva N, Pavlova M, Levina A, Khlebaeva D, Lyubashina O, et al. Selected rat strains Ht, Lt as a model for the study of dysadaptation states dependent on the level of excitability of the nervous system. Lab Anim Sci Rus. 2018;1(3):12–22.
  5. 5. Sivachenko I, et al. Impulse activity and genome instability in neurons of the amygdala complex in rats of selected strains with contrast excitability of the nervous system in normal and stress conditions. Zh Vyssh Nerv Deyat Im IP Pavlova. 2020;70:655–67.
  6. 6. Vylegzhanina A, Shalaginova I, Korolevich D, Katserov D, Semenova A, Sidorova M, et al. Strain-specific trajectories of behavioural, neuroinflammatory, and microbiota changes under chronic stress in rats with contrast levels of nervous system excitability. BIOCELL. 2025;0(0):1–10.
  7. 7. Ghasemi M, Navidhamidi M, Rezaei F, Azizikia A, Mehranfard N. Anxiety and hippocampal neuronal activity: relationship and potential mechanisms. Cogn Affect Behav Neurosci. 2022;22(3):431–49. pmid:34873665
  8. 8. Wu X, Lu Y, Dong Y, Zhang G, Zhang Y, Xu Z, et al. The inhalation anesthetic isoflurane increases levels of proinflammatory TNF-α, IL-6, and IL-1β. Neurobiol Aging. 2012;33(7):1364–78. pmid:21190757
  9. 9. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. 6th ed. Academic Press; 2007.
  10. 10. Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15–21. pmid:23104886
  11. 11. Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550. pmid:25516281
  12. 12. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, et al. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol. 2003;4(5):P3. pmid:12734009
  13. 13. Tang D, Chen M, Huang X, Zhang G, Zeng L, Zhang G, et al. SRplot: a free online platform for data visualization and graphing. PLoS One. 2023;18(11):e0294236. pmid:37943830
  14. 14. Enright AJ, Van Dongen S, Ouzounis CA. An efficient algorithm for large-scale detection of protein families. Nucleic Acids Res. 2002;30(7):1575–84. pmid:11917018
  15. 15. Pechlivani N, Kearney KJ, Ajjan RA. Fibrinogen and antifibrinolytic proteins: interactions and future therapeutics. Int J Mol Sci. 2021;22(22):12537. pmid:34830419
  16. 16. Zattoni M, Mearelli M, Vanni S, Colini Baldeschi A, Tran TH, Ferracin C, et al. Serpin signatures in prion and Alzheimer’s diseases. Mol Neurobiol. 2022;59(6):3778–99. pmid:35416570
  17. 17. Shalaginova I, Pavlova M, Dyuzhikova N. Аmygdala DEGs are associated with the immune system function: a comparative transcriptomic study of high- and low-excitability rat strains. PLoS One. 2025;20(5):e0323325. pmid:40373086
  18. 18. Lee I, Wang X, Ling I, Verma S, Eck C, Blanche W, et al. The complement regulator CD55 modulates TLR9 signaling and supports survival in marginal zone B cells. J Immunol. 2025;214(9):2211–20. pmid:40570142
  19. 19. van Beek J, van Meurs M, ’t Hart BA, Brok HPM, Neal JW, Chatagner A, et al. Decay-accelerating factor (CD55) is expressed by neurons in response to chronic but not acute autoimmune central nervous system inflammation associated with complement activation. J Immunol. 2005;174(4):2353–65. pmid:15699172
  20. 20. Illes P, Khan TM, Rubini P. Neuronal P2X7 receptors revisited: do they really exist? J Neurosci. 2017;37:7049–62.
  21. 21. Kaczmarek-Hajek K, Zhang J, Kopp R, Grosche A, Rissiek B, Saul A, et al. Re-evaluation of neuronal P2X7 expression using novel mouse models and a P2X7-specific nanobody. Elife. 2018;7:e36217. pmid:30074479
  22. 22. Huang S, Dong W, Lin X, Xu K, Li K, Xiong S, et al. Disruption of the Na+/K+-ATPase-purinergic P2X7 receptor complex in microglia promotes stress-induced anxiety. Immunity. 2024;57(3):495-512.e11. pmid:38395698
  23. 23. Campagno KE, Lu W, Jassim AH, Albalawi F, Cenaj A, Tso H-Y, et al. Rapid morphologic changes to microglial cells and upregulation of mixed microglial activation state markers induced by P2X7 receptor stimulation and increased intraocular pressure. J Neuroinflammation. 2021;18(1):217. pmid:34544431
  24. 24. Sturno AM, Hassell JE Jr, Lanaspa MA, Bruce KD. Do microglia metabolize fructose in Alzheimer’s disease? J Neuroinflammation. 2025;22(1):85. pmid:40089786
  25. 25. Kojo A, Yamada K, Yamamoto T. Glucose transporter 5 (GLUT5)-like immunoreactivity is localized in subsets of neurons and glia in the rat brain. J Chem Neuroanat. 2016;74:55–70. pmid:27036089
  26. 26. Mizuno TM, Lew PS, Jhanji G. Regulation of the fructose transporter gene Slc2a5 expression by glucose in cultured microglial cells. Int J Mol Sci. 2021;22(23):12668. pmid:34884473
  27. 27. Sjöstedt E, Zhong W, Fagerberg L, Karlsson M, Mitsios N, Adori C, et al. An atlas of the protein-coding genes in the human, pig, and mouse brain. Science. 2020;367(6482):eaay5947. pmid:32139519
  28. 28. Cole DC, Chung Y, Gagnidze K, Hajdarovic KH, Rayon-Estrada V, Harjanto D, et al. Loss of APOBEC1 RNA-editing function in microglia exacerbates age-related CNS pathophysiology. Proc Natl Acad Sci U S A. 2017;114(50):13272–7. pmid:29167375
  29. 29. Kankowski S, Förstera B, Winkelmann A, Knauff P, Wanker EE, You XA, et al. A novel RNA editing sensor tool and a specific agonist determine neuronal protein expression of RNA-edited glycine receptors and identify a genomic APOBEC1 dimorphism as a new genetic risk factor of epilepsy. Front Mol Neurosci. 2018;10:439. pmid:29375302
  30. 30. Parveen F, Bender D, Law S-H, Mishra VK, Chen C-C, Ke L-Y. Role of ceramidases in sphingolipid metabolism and human diseases. Cells. 2019;8(12):1573. pmid:31817238
  31. 31. Lin H, Wu S, Weng Z, Wang H, Shi R, Tian M, et al. Tianma formula alleviates dementia via ACER2-mediated sphingolipid signaling pathway involving Aβ. Evid Based Complement Alternat Med. 2021;2021:6029237. pmid:35069753
  32. 32. Zhang Z, Hao C-J, Li C-G, Zang D-J, Zhao J, Li X-N, et al. Mutation of SLC35D3 causes metabolic syndrome by impairing dopamine signaling in striatal D1 neurons. PLoS Genet. 2014;10(2):e1004124. pmid:24550737
  33. 33. Wei Z-B, Yuan Y-F, Jaouen F, Ma M-S, Hao C-J, Zhang Z, et al. SLC35D3 increases autophagic activity in midbrain dopaminergic neurons by enhancing BECN1-ATG14-PIK3C3 complex formation. Autophagy. 2016;12(7):1168–79. pmid:27171858
  34. 34. Rybakin V, Stumpf M, Schulze A, Majoul IV, Noegel AA, Hasse A. Coronin 7, the mammalian POD-1 homologue, localizes to the Golgi apparatus. FEBS Lett. 2004;573(1–3):161–7. pmid:15327992
  35. 35. Bhattacharya K, Swaminathan K, Peche VS, Clemen CS, Knyphausen P, Lammers M, et al. Novel Coronin7 interactions with Cdc42 and N-WASP regulate actin organization and Golgi morphology. Sci Rep. 2016;6:25411. pmid:27143109
  36. 36. Wu Q, Maniatis T. A striking organization of a large family of human neural cadherin-like cell adhesion genes. Cell. 1999;97(6):779–90. pmid:10380929
  37. 37. Osuka T, Yamamoto H, Yagi T. Diversity of clustered protocadherin-α genes in neuronal identity and its role in short-term specific associative memory formation. Sci Rep. 2025;15(1):19334. pmid:40456859
  38. 38. Serratto GM, Pizzi E, Murru L, Mazzoleni S, Pelucchi S, Marcello E, et al. The epilepsy-related protein PCDH19 regulates tonic inhibition, GABAAR kinetics, and the intrinsic excitability of hippocampal neurons. Mol Neurobiol. 2020;57(12):5336–51. pmid:32880860
  39. 39. Alder J, Thakker-Varia S, Bangasser DA, Kuroiwa M, Plummer MR, Shors TJ, et al. Brain-derived neurotrophic factor-induced gene expression reveals novel actions of VGF in hippocampal synaptic plasticity. J Neurosci. 2003;23(34):10800–8. pmid:14645472
  40. 40. Moss A, Ingram R, Koch S, Theodorou A, Low L, Baccei M, et al. Origins, actions and dynamic expression patterns of the neuropeptide VGF in rat peripheral and central sensory neurones following peripheral nerve injury. Mol Pain. 2008;4:62. pmid:19077191
  41. 41. Quinn JP, Kandigian SE, Trombetta BA, Arnold SE, Carlyle BC. VGF as a biomarker and therapeutic target in neurodegenerative and psychiatric diseases. Brain Commun. 2021;3(4):fcab261. pmid:34778762
  42. 42. Chipman PH, Fung CCA, Pazo Fernandez A, Sawant A, Tedoldi A, Kawai A, et al. Astrocyte GluN2C NMDA receptors control basal synaptic strengths of hippocampal CA1 pyramidal neurons in the stratum radiatum. Elife. 2021;10:e70818. pmid:34693906
  43. 43. Traynelis SF, Wollmuth LP, McBain CJ, Menniti FS, Vance KM, Ogden KK, et al. Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev. 2010;62(3):405–96. pmid:20716669
  44. 44. Stubbs T, Koemeter-Cox A, Bingman JI, Zhao F, Kalyanasundaram A, Rowland LA, et al. Disruption of dopamine receptor 1 localization to primary cilia impairs signaling in striatal neurons. J Neurosci. 2022;42(35):6692–705. pmid:35882560
  45. 45. Wang H, Li Y, Li X, Sun Z, Yu F, Pashang A, et al. The primary cilia are associated with the axon initial segment in neurons. Adv Sci (Weinh). 2025;12(9):e2407405. pmid:39804991
  46. 46. Strobel MR, Zhou Y, Qiu L, Hofer AM, Chen X. Temporal ablation of the ciliary protein IFT88 alters normal brainwave patterns. Sci Rep. 2025;15(1):347. pmid:39747370
  47. 47. Tang J, Frankel A, Cook RJ, Kim S, Paik WK, Williams KR, et al. PRMT1 is the predominant type I protein arginine methyltransferase in mammalian cells. J Biol Chem. 2000;275(11):7723–30. pmid:10713084
  48. 48. Lee S-Y, Vuong TA, Wen X, Jeong H-J, So H-K, Kwon I, et al. Methylation determines the extracellular calcium sensitivity of the leak channel NALCN in hippocampal dentate granule cells. Exp Mol Med. 2019;51(10):1–14. pmid:31601786
  49. 49. Raess MA, Friant S, Cowling BS, Laporte J. WANTED - Dead or alive: Myotubularins, a large disease-associated protein family. Adv Biol Regul. 2017;63:49–58. pmid:27666502
  50. 50. Bolis A, Coviello S, Visigalli I, Taveggia C, Bachi A, Chishti AH, et al. Dlg1, Sec8, and Mtmr2 regulate membrane homeostasis in Schwann cell myelination. J Neurosci. 2009;29(27):8858–70. pmid:19587293
  51. 51. Bączyńska E, Zaręba-Kozioł M, Ruszczycki B, Krzystyniak A, Wójtowicz T, Bijata K, et al. Stress resilience is an active and multifactorial process manifested by structural, functional, and molecular changes in synapses. Neurobiol Stress. 2024;33:100683. pmid:39524934
  52. 52. Chater TE, Goda Y. The shaping of AMPA receptor surface distribution by neuronal activity. Front Synaptic Neurosci. 2022;14:833782. pmid:35387308
  53. 53. Chugh P, Paluch EK. The actin cortex at a glance. J Cell Sci. 2018;131(14):jcs186254. pmid:30026344
  54. 54. Gene Ontology Consortium. The Gene Ontology resource: enriching a GOld mine. Nucleic Acids Res. 2021;49(D1):D325–34. pmid:33290552
  55. 55. Kole MHP, Stuart GJ. Signal processing in the axon initial segment. Neuron. 2012;73(2):235–47. pmid:22284179
  56. 56. Marcelin B, et al. Differential dorso-ventral distributions of Kv4.2 and HCN proteins confer distinct integrative properties to hippocampal CA1 pyramidal cell distal dendrites. J Biol Chem. 2012;287:17656–61.
  57. 57. Cho W-H, Noh K, Lee BH, Barcelon E, Jun SB, Park HY, et al. Hippocampal astrocytes modulate anxiety-like behavior. Nat Commun. 2022;13(1):6536. pmid:36344520
  58. 58. Bonifacino JS, Rojas R. Retrograde transport from endosomes to the trans-Golgi network. Nat Rev Mol Cell Biol. 2006;7(8):568–79. pmid:16936697
  59. 59. Shulyatnikova T, Shavrin V. Mobilisation and redistribution of multivesicular bodies to the endfeet of reactive astrocytes in acute endogenous toxic encephalopathies. Brain Res. 2021;1751:147174. pmid:33172595
  60. 60. Kim EK, Choi E-J. Pathological roles of MAPK signaling pathways in human diseases. Biochim Biophys Acta. 2010;1802(4):396–405. pmid:20079433
  61. 61. Albert-Gascó H, Ros-Bernal F, Castillo-Gómez E, Olucha-Bordonau FE. MAP/ERK signaling in developing cognitive and emotional function and its effect on pathological and neurodegenerative processes. Int J Mol Sci. 2020;21(12):4471. pmid:32586047
  62. 62. Cobley JN, Fiorello ML, Bailey DM. 13 reasons why the brain is susceptible to oxidative stress. Redox Biol. 2018;15:490–503. pmid:29413961
  63. 63. Sorg BA, Berretta S, Blacktop JM, Fawcett JW, Kitagawa H, Kwok JCF, et al. Casting a wide net: role of perineuronal nets in neural plasticity. J Neurosci. 2016;36(45):11459–68. pmid:27911749
  64. 64. Fawcett JW, Oohashi T, Pizzorusso T. The roles of perineuronal nets and the perinodal extracellular matrix in neuronal function. Nat Rev Neurosci. 2019;20:451–65.
  65. 65. Groten CJ, MacVicar BA. Mitochondrial Ca2 uptake by the MCU facilitates pyramidal neuron excitability and metabolism during action potential firing. Commun Biol. 2022;5:900.
  66. 66. Nicoli AL, Al Abed AS, Hulme SR, Das A, Gauthier-Coles G, Bröer A, et al. Glutamine transport via amino acid transporter NTT4 (SLC6A17) maintains presynaptic glutamate supply at excitatory synapses in the CNS. Prog Neurobiol. 2025;250:102785. pmid:40436200
  67. 67. Najera K, Fagan BM, Thompson PM. SNAP-25 in major psychiatric disorders: a review. Neuroscience. 2019;420:79–85.
  68. 68. Antonucci F, Corradini I, Fossati G, Tomasoni R, Menna E, Matteoli M. SNAP-25, a known presynaptic protein with emerging postsynaptic functions. Front Synaptic Neurosci. 2016;8:7. pmid:27047369
  69. 69. Numakawa T, Kajihara R. Involvement of brain-derived neurotrophic factor signaling in the pathogenesis of stress-related brain diseases. Front Mol Neurosci. 2023;16:1247422. pmid:37781095
  70. 70. Biundo F, Del Prete D, Zhang H, Arancio O, D’Adamio L. A role for tau in learning, memory and synaptic plasticity. Sci Rep. 2018;8(1):3184. pmid:29453339
  71. 71. Robbins M, Clayton E, Kaminski Schierle GS. Synaptic tau: a pathological or physiological phenomenon? Acta Neuropathol Commun. 2021;9:149.
  72. 72. Sanz-Gálvez R, Falardeau D, Kolta A, Inglebert Y. The role of astrocytes from synaptic to non-synaptic plasticity. Front Cell Neurosci. 2024;18:1477985. pmid:39493508
  73. 73. Berman RF, et al. Gfap mutation and astrocyte dysfunction lead to a neurodegenerative profile with impaired synaptic plasticity and cognitive deficits in a rat model of Alexander disease. eNeuro. 2025;12(ENEURO.0504-24.2025):1–15.
  74. 74. Yang G, Gray TS, Sigmund CD, Cassell MD. The angiotensinogen gene is expressed in both astrocytes and neurons in murine central nervous system. Brain Res. 1999;817(1–2):123–31. pmid:9889347
  75. 75. Gowrisankar YV, Clark MA. Regulation of angiotensinogen expression by angiotensin II in spontaneously hypertensive rat primary astrocyte cultures. Brain Res. 2016;1643:51–8. pmid:27131988
  76. 76. Karnik SS, et al. International Union of Basic and Clinical Pharmacology. XCIX. angiotensin receptors: interpreters of pathophysiological angiotensinergic stimuli. Pharmacol Rev. 2015;67:754–819.
  77. 77. Choi J-S, Kim H-Y, Cha J-H, Choi J-Y, Chun M-H, Lee M-Y. Upregulation of vascular endothelial growth factor receptors Flt-1 and Flk-1 in rat hippocampus after transient forebrain ischemia. J Neurotrauma. 2007;24(3):521–31. pmid:17402857
  78. 78. Pandey P, Khan F, Upadhyay TK, Seungjoon M, Park MN, Kim B. New insights about the PDGF/PDGFR signaling pathway as a promising target to develop cancer therapeutic strategies. Biomed Pharmacother. 2023;161:114491. pmid:37002577
  79. 79. Sil S, Periyasamy P, Thangaraj A, Chivero ET, Buch S. PDGF/PDGFR axis in the neural systems. Mol Aspects Med. 2018;62:63–74. pmid:29409855